{
    "Trade/Device Name(s)": [
        "Optium Plus Blood Glucose Test Strips",
        "Precision Xtra Plus Blood Glucose Test Strips",
        "MediSense Optium Plus Blood Glucose Test Strips",
        "Precision Easy Blood Glucose Test Strips",
        "MediSense Optium Easy Blood Glucose Test Strips"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K051213",
    "Predicate Device Reference 510(k) Number(s)": [
        "K023256"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LFR",
        "NBW"
    ],
    "Summary Letter Date": "May 11, 2005",
    "Summary Letter Received Date": "May 17, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Precision Xtra Advanced Diabetes Management System"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric biosensor technology"
    ],
    "Methodologies": [
        "Quantitative glucose measurement"
    ],
    "Submission Type(s)": [
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for Optium Plus and Precision Xtra Plus Blood Glucose Test Strips for quantitative measurement of glucose in fresh capillary blood using amperometric biosensor technology.",
    "Indications for Use Summary": "Intended for in-vitro quantitative measurement of glucose in fresh capillary blood for self-testing by lay users or use by health care professionals, for monitoring blood glucose concentrations in persons with diabetes and other conditions.",
    "fda_folder": "Clinical Chemistry"
}